Merck and Co Inc (MRK) 93.13 +1.13 (+1.23%)
93.13 +1.13 (+1.23%)
US58933Y1055 - Common Stock - After market: 93.3 +0.17 (+0.18%)
Buy % Consensus
Analysts have set a mean price target of 99.07. This target is 6.38% above the current price.
MRK was analyzed by 33 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about MRK.
In the previous month the buy percentage consensus was at a similar level.
MRK was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-29 | SVB Leerink | Maintains | Outperform |
| 2022-04-29 | Wells Fargo | Maintains | Overweight |
| 2022-04-29 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-21 | SVB Leerink | Maintains | Outperform |
| 2022-04-12 | Barclays | Maintains | Overweight |
| 2022-02-04 | SVB Leerink | Maintains | Outperform |
| 2022-01-28 | JP Morgan | Maintains | Overweight |
| 2021-12-16 | Daiwa Capital | Initiate | Neutral |
| 2021-12-13 | UBS | Downgrade | Buy -> Neutral |
| 2021-12-09 | Wells Fargo | Initiate | Overweight |
| 2021-12-07 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-11-29 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-29 | Citigroup | Downgrade | Buy -> Neutral |
| 2021-11-19 | BMO Capital | Initiate | Market Perform |
| 2021-11-01 | Argus Research | Upgrade | Hold -> Buy |
| 2021-11-01 | Barclays | Maintains | Overweight |
| 2021-10-29 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-22 | SVB Leerink | Maintains | Outperform |
| 2021-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-11 | Berenberg | Maintains | Hold |
| 2021-10-08 | Barclays | Maintains | Overweight |
| 2021-10-04 | SVB Leerink | Maintains | Outperform |
| 2021-09-07 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-07-30 | SVB Leerink | Maintains | Outperform |
| 2021-06-09 | JP Morgan | Maintains | Overweight |
| 2021-06-07 | Truist Securities | Maintains | Buy |
| 2021-06-03 | SVB Leerink | Maintains | Outperform |
| 2021-05-20 | Argus Research | Downgrade | Buy -> Hold |
| 2021-04-30 | SVB Leerink | Maintains | Outperform |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA